Prevalence of Advanced Fibrosis in Patients Living With HIV
This research is focused on understanding how many people living with HIV also have advanced liver scarring, known as fibrosis. We know that conditions like diabetes, heart disease, and obesity are becoming more common globally, even in people with HIV. These conditions can sometimes lead to liver problems, including fatty liver disease. The study aims to look at people attending outpatient clinics who live with HIV to see how often this severe liver scarring occurs. After this initial check, participants will be followed for up to 10 years to learn more about the long-term effects and importance of these findings for their health. This information will help doctors better care for people with HIV and related liver issues.
At a glance
What is this study about?
Globally, we've seen a big change in health problems. In the past, infections were the main concern, but now, long-term conditions like diabetes, heart disease, and cancer are becoming much more common. These conditions, often linked to things like being overweight or having issues with how the body uses sugar, are on the rise everywhere, even in developing countries.
This particular study is looking into how often people living with HIV also have a serious liver condition called advanced fibrosis. Fibrosis is a type of scarring in the liver, and if it becomes advanced, it can be quite serious. Since fatty liver disease is becoming more common, even in people with HIV, it's really important to understand this link.
The study will involve people who are living with HIV and attend outpatient clinics. Researchers will check to see how many of them have this advanced liver scarring. After this initial check, the study will continue to follow these individuals for up to 10 years. This long-term follow-up is important to see what impact this liver scarring has on their health over time and to understand its overall importance. This research will help doctors and healthcare providers give better care and advice to people living with HIV.
Key takeaways
- This study investigates liver scarring in people living with HIV.
- It aims to understand how common severe liver scarring (fibrosis) is.
- Participants will be followed for up to 10 years to learn about long-term health effects.
- The study helps improve future care for people with HIV and liver issues.
- It primarily involves an initial assessment and tracking health records.
Who may be eligible?
To take part in this study, you need to be an adult, 18 years old or older, and you must agree to participate by giving your informed consent. This means you'll receive all the information about the study and decide if you want to join.
There are a few reasons why someone might not be able to join. If you are pregnant, unfortunately, you won't be able to participate. Also, if you have a medical condition that doctors expect to shorten your life to less than 12 months, you won't be eligible for this study. These rules are in place to make sure the study is safe and that it collects the right kind of information.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you living with HIV?
- Are you able to give your informed consent to take part?
- Are you not currently pregnant?
- Do you expect to live for at least 12 more months based on your current health?
What does participation involve?
This study is a one-off assessment to understand liver scarring. You won't be given any new medications as part of this study. Your participation involves an initial check to look for advanced liver scarring. After this initial assessment, the researchers plan to keep track of your health for up to 10 years to see how this liver condition might change or affect you over time. This follow-up will likely involve reviewing your medical records rather than requiring frequent visits or tests specifically for the study. The total duration of your involvement, primarily for observation, could be up to 10 years.
Potential risks and benefits
Locations (2)
- University Medical Center of the Johannes Gutenber UniveristyVerified postcodeMainz, Germany
- University Medical Center of the Johannes Gutenberg UniversityVerified postcodeMainz, Germany
Common questions
What is 'advanced fibrosis'?
Advanced fibrosis means there is severe scarring in your liver, which can affect how well it works.
Why is this study important for people with HIV?
We want to understand how common severe liver scarring is in people with HIV, as liver conditions are becoming more frequent, and this could help improve their care.
Will I get any new medicine in this study?
No, this study is about understanding a health condition, not trying out new medicines. You will not be given any new treatments as part of it.
How long will the study last for me?
After an initial check, researchers will follow your health records for up to 10 years to see the long-term impact of any liver scarring.
What does 'cross-sectional' mean?
It means the study looks at a group of people at one particular point in time to see how common a condition is.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.